Name: ResMed (RMD) CEO on GLP-1 Drugs: "This is a Really Exciting Moment for Global Healthcare System"
Uploaded: 2024-08-08T20:25:49.613-05:00
Duration: 7 min 36 s
Description: @ResMedAmericas CEO Michael Farrell joins Oliver Renick to talk about the rise of GLP-1 drugs and its impact on the CPAP Therapy. He also discusses A.I.'s use in sleep and respiratory care, and ResMed's latest earnings.

Morning Movers

Opening Bell With Nicole Petallides

Morning Trade Live

Trading 360

Fast Market

Next Gen Investing

The Watch List

Market On Close

Market Overtime

Inside the Mind of a Trader

Your First Trade

The Wrap

Liz Ann Live

Schwab 2026 Outlook

<p>Market on Close is Schwab Network’s signature end-of-day show—live from Wall Street and Chicago—where market intel meets real-time momentum. With Sam Vadas at the NYSE and Marley Kayden anchoring from Chicago HQ, we connect the dots between traders, catalysts, and tomorrow’s opening bell.&nbsp;</p>

Daily insights for every investor

Schwab Network's Newsletters

<p>@ResMedAmericas CEO Michael Farrell joins Oliver Renick to talk about the rise of GLP-1 drugs and its impact on the CPAP Therapy. He also discusses A.I.'s use in sleep and respiratory care, and ResMed's latest earnings.</p>

ResMed (RMD) CEO on GLP-1 Drugs: "This is a Really Exciting Moment for Global Healthcare System"

Expert commentary about top moving stocks, sectors, and commodities, along with CEO and analyst interviews.

Market News